As strikes continue on Iran’s nuclear facilities, the real danger isn’t the explosion, but what happens if critical safety systems fail—and how that risk could spread across the Gulf.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Months into a supposed ceasefire in Gaza, doctors still have to smuggle in basic medical supplies—and treat new casualties of war.
Evidence suggests reactivations of the varicella-zoster virus may accelerate aging and raise dementia risk. Now scientists want to know if vaccines and antivirals could help protect the brain.
The biggest US measles outbreak in decades may be over sooner than expected.
For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.
The MAHA movement is recasting the term—developed in the 1980s to help protect patients against paternalistic medicine—in service of its own agenda.
A recent study suggests that left-handed people have an advantage in competitive contexts, while righties tend to cooperate better.
Women’s sleep apnea symptoms differ from men’s and can often be confused with hormonal shifts. Researchers are working to close the detection gap.
A 2023 law championed by Republicans requires the CDC have a director confirmed by the Senate. For months, though, it’s had only acting directors—and the White House won’t say when that will change.